Skip to main content

Closed

APRE: Aprea Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin-10649.9%

ROIC-29.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio8.92×

Aprea Therapeutics, Inc.

APRENASDAQ Global Select·USD·Closed

Aprea Therapeutics, Inc.

APRENASDAQ·USD·Closed

$0.62

−2.36%

$0.62

−$0.02 (2.36%)

52W Range

6thpctl

Volume

0.40×avg

Mkt Cap

4.03MUSD

P/E

-0.4TTM

Div Yield

–ann

52W Range

6thpctl

Volume

0.40×avg

Market Cap

4.03MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings